BioArctic inks pact with Novartis regarding treatment combining BrainTransporter technology with undisclosed target in neurodegeneration Ruchika Sharma31 Aug 2025 2:30 AM ISTStockholm: BioArctic AB (publ) has announced that the company has entered into an option, collaboration and license agreement with Novartis...
Biogen, Eisai get USFDA nod for Leqembi Iqlik Subcutaneous Injection for maintenance dosing for early Alzheimer's Disease Ruchika Sharma30 Aug 2025 4:02 PM ISTTokyo: Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License...
Hormone therapy type matters for memory performance after menopause, reveals study Dr. Kamal Kant Kohli29 Aug 2025 8:45 PM ISTThe type of estradiol-based hormone therapy taken during and after menopause, such as patches or pills, may be associated with differences in memory...
Diabetes and Vascular Risk Factors Linked to Poorer Cognitive Recovery After Traumatic Brain Injury: JAMA Jacinthlyn Sylvia29 Aug 2025 8:30 PM ISTA new study published in the Journal of American Medical Association revealed that individuals with diabetes had slower recovery in processing...
SGLT2 Inhibitors May Shield Against Dementia in Older Adults with Type 2 Diabetes: Study Suggests Medha Baranwal29 Aug 2025 9:30 AM ISTGermany: Older adults with type 2 diabetes mellitus (T2DM) who receive sodium-glucose cotransporter-2 inhibitors (SGLT2i) may have a lower risk of...
Gabapentin Use Linked to Dementia and Cognitive Impairment Risk among low backache patients: BMJ Jacinthlyn Sylvia28 Aug 2025 8:15 PM ISTA new study published in the journal of Regional Anesthesia and Pain Medicine showed that adults with gabapentin-treated persistent low back pain had...
Mediterranean diet may offset genetic risk of Alzheimer's, suggests study Dr. Kamal Kant Kohli28 Aug 2025 8:00 AM ISTA new study led by investigators from Mass General Brigham, Harvard T.H. Chan School of Public Health, and the Broad Institute of MIT and Harvard...
Phase 3 NIMBLE Trial Reports Topline Results for Cemdisiran in generalized myasthenia gravis Dr. Kamal Kant Kohli27 Aug 2025 8:45 PM ISTThe phase 3 NIMBLE trial evaluated cemdisiran, a subcutaneous small interfering RNA therapy targeting complement factor 5, in adults with generalized...
High concentration THC associated with schizophrenia, psychosis, and other unfavorable mental health outcomes: Study Dr. Kamal Kant Kohli26 Aug 2025 8:30 PM ISTA systematic review analyzed associations of high-concentration delta-9-tetrahydrocannabinol (THC) cannabis products with mental health outcomes. The...
Study Reveals Your Brain Burns Fat at Night to Prevent Sugar Crashes Anshika Mishra26 Aug 2025 8:00 AM ISTA recent study published in Molecular Metabolism by researchers at the University of Michigan has identified a specific group of neurons in the...
Adjunctive Argatroban or Eptifibatide Shows No Benefit with Thrombolysis in Thrombectomy Patients: JAMA Jacinthlyn Sylvia26 Aug 2025 7:30 AM ISTA recent study published in the Journal of American Medical Association revealed that adding argatroban or eptifibatide to intravenous...
Stress Hyperglycemia Ratio and Hypertension Closely Associated with Stroke Risk: Study Jacinthlyn Sylvia25 Aug 2025 8:45 AM ISTA new study published in the BMC Cardiovascular Diabetology found the importance of a novel metabolic marker, the stress hyperglycemia ratio (SHR), in...
